Skip to main content
OpenTrials

Clinical trial condition

Liver Cirrhosis

Explore clinical trials studying Liver Cirrhosis. Study availability and eligibility vary by location and protocol.

163 public trials 37 recruiting studies
Refine in advanced search Browse all conditions

Liver Cirrhosis trial results

Active, Not Recruiting

Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)

NCT04526665

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • The Institute for Liver Health Chandler, Arizona, United States
  • Keck Medical Center of USC Los Angeles, California, United States
  • Ruane Clinical Research Group Inc. Los Angeles, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
View all 115 locations
View Trial Details
Active, Not Recruiting

A Study of Elafibranor in Adult Japanese Participants With Primary Biliary Cholangitis (PBC)

NCT06730061

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • Nippon Medical School - Chiba Hokusoh Hospital Chiba, Japan
  • Fukushima Medical University Hospital Fukushima, Japan
  • Chugoku Rosai Hospital Hiroshima, Japan
  • Teine Keijinkai Hospital Hokkaido, Japan
View all 16 locations
View Trial Details
Active, Not Recruiting

Study to Evaluate the Efficacy and Safety of K-808 (Pemafibrate) in Participants With Primary Biliary Cholangitis (PBC) With Inadequate Response to Ursodeoxycholic Acid (UDCA) and/or Obeticholic Acid (OCA) Treatment.

NCT06247735

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • UA Thomas D. Boyer Liver Institute Tucson, Arizona, United States
  • Southern California Research Center - Coronado Coronado, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Velocity Clinical Research Santa Ana, California, United States
View all 38 locations
View Trial Details
Active, Not Recruiting

Linerixibat Long-term Safety, and Tolerability Study

NCT04167358

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +8 more
Locations
  • GSK Investigational Site Davis, California, United States
  • GSK Investigational Site West Hollywood, California, United States
  • GSK Investigational Site Miami, Florida, United States
  • GSK Investigational Site Detroit, Michigan, United States
View all 94 locations
View Trial Details
Active, Not Recruiting

Open-Label Extension Study of Saroglitazar Magnesium in Participants With Primary Biliary Cholangitis

NCT06427395

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • Zydus US013 Los Angeles, California, United States
  • Zydus US011 Pasadena, California, United States
  • Zydus US043 Sacramento, California, United States
  • Zydus US022 Aurora, Colorado, United States
View all 28 locations
View Trial Details
Active, Not Recruiting

Patients With Primary Biliary Cholangitis

NCT07573514

Conditions
Adenocarcinoma, Bile Duct Diseases, Biliary Tract Diseases, +20 more
Locations
  • Fondazione Policlinico Universitaro A. Gemelli IRCSS,UOC Medicina Interna e Gastroenterologia,Largo A. Gemelli, Roma, Italy
View Trial Details
Active, Not Recruiting

Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC)

NCT03301506

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • Arkansas Diagnostic Center Little Rock, Arkansas, United States
  • Stanford University School of Medicine Palo Alto, California, United States
  • California Liver Research Institute Pasadena, California, United States
  • University of California Davis Medical Center Sacramento, California, United States
View all 109 locations
View Trial Details
Active, Not Recruiting

CS0159 in Chinese Patients With PBC (Primary Biliary Cholangitis)

NCT05896124

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • The First Affiliated Hospital of USTC Anhui Provincial Hospital Hefei, Anhui, China
  • Beijing Friendship Hospital, Capitai Medical University Beijing, Beijing Municipality, China
  • Beijing Youan Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
View all 16 locations
View Trial Details

Related conditions